AKT1 and pancreatic neoplasm: This result is consistent with the effect of Rac1 inhibitor NSC23766, suggesting that Rac1 plays an essential role in the IR-induced AKT activation in CD18/HPAF pancreatic cancer cells whereas it has little effect on the IR-induced ERK1/2 activation in these cells.